United States to India: Device Import Trade Route

The United States to India Device corridor is one of India's established pharmaceutical import routes from United States, with 65 shipments documented worth a combined $330.9K USD. The route is dominated by BARD SHANNON LIMITED, which alone accounts for roughly 63% of all import value, reflecting the consolidated nature of United States's device export sector.

Across 11 active United States suppliers, the average shipment value stands at $5.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 34.5%, placing it at rank #13 among India's top device import origins globally.

On the Indian buyer side, key Indian importers include BARD INDIA HEALTHCARE PRIVATE LIMITED, CIPLA LIMITED, LUPIN LIMITED and 4 others. BARD INDIA HEALTHCARE PRIVATE LIMITED is the single largest Indian importer with 38 shipments valued at $209.6K USD.

India's device imports from United States are driven primarily by a handful of large-scale United States manufacturers. BARD SHANNON LIMITED with 38 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — Indian buyers benefit from United States supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BARD SHANNON LIMITED, NOVEL LABORATORIES INC, ESPEE BIOPHARMA & FINECHEM LLC. — together account for 83% of total trade value on this route. The average shipment value of $5.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as arista ah 3g intl biosurgicals medical device for surgical use item no sm0002 and opvee nalmefene nasal spray 2 7mg two unit dose nasal spray devices for testing purpose only opvee nalmefene nasal spray 2 7mg two unit dose nasal s, suggesting that Indian buyers tend to consolidate orders across related product lines from the same United States supplier.

On the buying side, BARD INDIA HEALTHCARE PRIVATE LIMITED is the largest importer with 38 shipments worth $209.6K USD — representing 63% of all device imports from United States on this route. A total of 7 buyers are active on this corridor.